Guangjiang Jiang

435 total citations
7 papers, 133 citations indexed

About

Guangjiang Jiang is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, Guangjiang Jiang has authored 7 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Hepatology and 2 papers in Molecular Biology. Recurrent topics in Guangjiang Jiang's work include Organ Transplantation Techniques and Outcomes (3 papers), Liver Disease and Transplantation (2 papers) and Cancer Mechanisms and Therapy (2 papers). Guangjiang Jiang is often cited by papers focused on Organ Transplantation Techniques and Outcomes (3 papers), Liver Disease and Transplantation (2 papers) and Cancer Mechanisms and Therapy (2 papers). Guangjiang Jiang collaborates with scholars based in China, Madagascar and Canada. Guangjiang Jiang's co-authors include Sunbin Ling, Xiao Xu, Shengjun Xu, Qifan Zhan, Qianwei Ye, Shusen Zheng, Qiaonan Shan, Junli Chen, Haiyang Xie and Xuyong Wei and has published in prestigious journals such as Advanced Science, Liver International and European Journal of Surgical Oncology.

In The Last Decade

Guangjiang Jiang

7 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangjiang Jiang China	6	59	52	31	31	19	7	133
Qifan Zhan China	6	41 0.7×	52 1.0×	20 0.6×	25 0.8×	18 0.9×	9	111
Pei-Ru Jin United States	3	55 0.9×	28 0.5×	17 0.5×	33 1.1×	10 0.5×	4	112
Suwan Sun China	7	84 1.4×	46 0.9×	64 2.1×	39 1.3×	9 0.5×	13	156
Valentina Uscătescu Romania	5	41 0.7×	51 1.0×	64 2.1×	14 0.5×	11 0.6×	11	344
Yunbo Xie China	5	75 1.3×	33 0.6×	44 1.4×	88 2.8×	14 0.7×	11	204
Hiroaki Kanzaki Japan	7	66 1.1×	76 1.5×	17 0.5×	37 1.2×	27 1.4×	19	164
Casey Rowe Australia	6	7 0.1×	40 0.8×	39 1.3×	8 0.3×	34 1.8×	14	125
Heather M. Duncan United States	5	133 2.3×	34 0.7×	151 4.9×	35 1.1×	8 0.4×	9	201
Martin Moehlen United States	6	19 0.3×	31 0.6×	24 0.8×	41 1.3×	13 0.7×	16	97
Motonori Shimizu Japan	5	93 1.6×	14 0.3×	74 2.4×	85 2.7×	31 1.6×	6	176

Countries citing papers authored by Guangjiang Jiang

Since Specialization

Citations

This map shows the geographic impact of Guangjiang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangjiang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangjiang Jiang more than expected).

Fields of papers citing papers by Guangjiang Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangjiang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangjiang Jiang. The network helps show where Guangjiang Jiang may publish in the future.

Co-authorship network of co-authors of Guangjiang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangjiang Jiang. A scholar is included among the top collaborators of Guangjiang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangjiang Jiang. Guangjiang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ling, Sunbin, et al.. (2022). Liver transplantation in patients with liver failure: Twenty years of experience from China. Liver International. 42(9). 2110–2116. 30 indexed citations

2.

Xu, Shengjun, Sunbin Ling, Qiaonan Shan, et al.. (2021). Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021). Advanced Science. 8(5). 1 indexed citations

3.

Ye, Qianwei, Sunbin Ling, Guangjiang Jiang, et al.. (2021). Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European Journal of Surgical Oncology. 47(10). 2533–2542. 11 indexed citations

4.

Jiang, Guangjiang, Sunbin Ling, Qifan Zhan, Li Zhuang, & Xiao Xu. (2021). Downstaging treatment for patients with hepatocelluar carcinoma before transplantation. Transplantation Reviews. 35(2). 100606–100606. 13 indexed citations

5.

Xu, Shengjun, Sunbin Ling, Qiaonan Shan, et al.. (2021). Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Advanced Science. 8(5). 2003042–2003042. 49 indexed citations

6.

Zhan, Qifan, Sunbin Ling, Yinan Deng, et al.. (2020). Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & pancreatic diseases international. 19(4). 349–357. 18 indexed citations

7.

Ling, Sunbin, Tingting Feng, Qifan Zhan, et al.. (2020). Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria. Annals of Translational Medicine. 8(4). 80–80. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact